Prolonged SARS-CoV-2-RNA Detection from Nasopharyngeal Swabs in an Oncologic Patient: What Impact on Cancer Treatment?
Open Access
- 8 February 2021
- journal article
- case report
- Published by MDPI AG in Current Oncology
- Vol. 28 (1), 847-852
- https://doi.org/10.3390/curroncol28010083
Abstract
The pandemic of SARS-CoV-2 is a serious global challenge affecting millions of people worldwide. Cancer patients are at risk for infection exposure and serious complications. A prompt diagnosis of SARS-CoV-2 infection is crucial for the timely adoption of isolation measures and the appropriate management of cancer treatments. In lung cancer patients the symptoms of infection 19 may resemble those exhibited by the underlying oncologic condition, possibly leading to diagnostic overlap and delays. Moreover, cancer patients might display a prolonged positivity of nasopharyngeal RT-PCR assays for SARS-CoV-2, causing long interruptions or delay of cancer treatments. However, the association between the positivity of RT-PCR assays and the patient’s infectivity remains uncertain. We describe the case of a patient with non-small cell lung cancer, and a severe ab extrinseco compression of the trachea, whose palliative radiotherapy was delayed because of the prolonged positivity of nasopharyngeal swabs for SARS-CoV-2. The patient did not show clinical symptoms suggestive of active infection, but the persistent positivity of RT-PCR assays imposed the continuation of isolation measures and the delay of radiotherapy for over two months. Finally, the negative result of SARS-CoV-2 viral culture allowed us to verify the absence of viral activity and to rule out the infectivity of the patient, who could finally continue her cancer treatment.Keywords
This publication has 24 references indexed in Scilit:
- False negative of RT‐PCR and prolonged nucleic acid conversion in COVID‐19: Rather than recurrenceJournal of Medical Virology, 2020
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, ChinaJAMA Oncology, 2020
- Cancer patients and research during COVID-19 pandemic: A systematic review of current evidenceCritical Reviews in Oncology/Hematology, 2020
- Challenges in lung cancer therapy during the COVID-19 pandemicThe Lancet. Respiratory Medicine, 2020
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trialInternational Journal of Antimicrobial Agents, 2020
- Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreakInternational Journal of Radiation Oncology*Biology*Physics, 2020
- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCREurosurveillance, 2020
- Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patientsEmerging Microbes & Infections, 2020
- The Crux of Ebola DiagnosticsThe Journal of Infectious Diseases, 2017
- Determination of 50% endpoint titer using a simple formulaWorld Journal of Virology, 2016